Inhibition of hepatitis C virus replication by semi-synthetic derivatives of glycopeptide antibiotics

Review article: specifically targeted anti-viral therapy for hepatitis C - a new era in therapy

(2010) C. M. Lange et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

New Lipoglycopeptides

(2010) George G. Zhanel et al.   DRUGS

Non-alcoholic fatty liver disease and its association with obesity, insulin resistance and increased serum levels of C-reactive protein in Hispanics

(2010) Arnoldo Riquelme et al.   LIVER INTERNATIONAL

Antiviral Therapy for Hepatitis C Virus: Beyond the Standard of Care

(2010) Leen Delang et al.   Viruses-Basel

Antiviral activity of geneticin against dengue virus

(2009) Xianchao G. Zhang et al.   ANTIVIRAL RESEARCH

HCV NS5B Polymerase Inhibitors

(2009) James R. Burton et al.   Clinics in Liver Disease

Statins potentiate thein vitroanti-hepatitis C virus activity of selective hepatitis C virus inhibitors and delay or prevent resistance development

(2009) Leen Delang et al.   HEPATOLOGY

Viral resistance to specifically targeted antiviral therapies for hepatitis C (STAT-Cs)

(2009) T. L. Kieffer et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Substituted imidazopyridines as potent inhibitors of HCV replication

(2009) Inge Vliegen et al.   JOURNAL OF HEPATOLOGY

PEG IFN alfa-2a vs. alfa-2b: And the winner is …?

(2009) Antonio Craxì   JOURNAL OF HEPATOLOGY

Antiviral resistance and specifically targeted therapy for HCV (STAT-C)

(2009) A. J. V. Thompson et al.   JOURNAL OF VIRAL HEPATITIS

HCV drug discovery aimed at viral eradication

(2009) R. F. Schinazi et al.   JOURNAL OF VIRAL HEPATITIS

Telaprevir with Peginterferon and Ribavirin for Chronic HCV Genotype 1 Infection

(2009) John G. McHutchison et al.   NEW ENGLAND JOURNAL OF MEDICINE

Hepatitis C virus hijacks host lipid metabolism

(2009) Gulam H. Syed et al.   TRENDS IN ENDOCRINOLOGY AND METABOLISM

Debio 025, a Cyclophilin Binding Molecule, Is Highly Efficient in Clearing Hepatitis C Virus (HCV) Replicon-Containing Cells When Used Alone or in Combination with Specifically Targeted Antiviral Therapy for HCV (STAT-C) Inhibitors

(2008) L. Coelmont et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Comparative In Vitro Anti-Hepatitis C Virus Activities of a Selected Series of Polymerase, Protease, and Helicase Inhibitors

(2008) J. Paeshuyse et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Vancomycin vs teicoplanin in the treatment of Gram-positive infections: a pharmacoeconomic analysis in a Turkish University Hospital

(2008) Aylin Acar Sancar et al.   PHARMACY WORLD & SCIENCE